Intellia Therapeutics Stock (NTLA)
Track Intellia Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
NTLA
Intellia Therapeutics
healthcare
$13.30
▲ +4.12 (+44.21%) past year
Market Cap
$1.76B
P/E Ratio
—
1Y Return
+44.21%
EPS (TTM)
-$3.53
Read the latest TheStreet Pro articles mentioning Intellia Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
7 articlesDaily Diary Mentions
0 mentionsNo diary mentions for NTLA yet.